Home › Pharmaxis has a new business model - is it now the least risky biotech stock?
 

Keywords :   


Pharmaxis has a new business model - is it now the least risky biotech stock?

2015-09-21 09:47:29| Biotech - Topix.net

Pharmaxis was still reeling from a shock rejection of its cystic fibrosis drug Bronchitol by US drug regulators when Gary Phillips took charge in March 2013. Amid a frantic search for cash, the former chief operating officer also had to make some tough decisions about the kind of Pharmaxis needed to be if it were to survive.

Tags: the now business least

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »